NGL-Impact® Aリガンド
Repligenが共同開発した次世代リガンドであるNGL-Impact® Aリガンドは、採取クロマトグラフィー用の高性能、低コストのProtein A樹脂を提供する画期的なソリューションです。
Next Generation Protein A Ligand
Co-developed with Navigo Proteins, NGL-Impact® A Ligand from Repligen was developed through a series of steps, including wild type Protein A shuffling, screening and multimerization. The result is a market-leading ligand that responds to the need for capture resins with better binding capacity, caustic stability and elution while reducing costs and improving process economics.
Repligen and Navigo will co-develop a portfolio of next generation ligands, utilizing Navigo’s proprietary Precision Capturing® technology platform.
商品化
Repligen entered an agreement to commercialize NGL-Impact® A Ligand using Purolite novel Praesto® agarose jetting base bead technology.
NGL-Impact® A has outstanding performance attributes when immobilized on jetted agarose bead technology, with ultra-high binding capacities and excellent alkaline stability. These attributes are important in providing improved monoclonal antibody capture to handle increased upstream product titres, and in allowing higher concentrations of sodium hydroxide (NaOH) for sanitization of resins.
The following data show the performance of Praesto Jetted A50 resin from Purolite, which uses the NGL-Impact® A ligand, compared with standard industry capture resins.
Manufacturing Centers of Excellence
Repligenは、ISO 9001品質管理システムに基づいて、バイオ医薬品業界向けの製品を開発・製造しています。高品質で安定した、堅牢な製品をタイムリーに提供し、お客様の事業継続性を保証することを重視しています。
Repligen manufacturing sites are located in Massachusetts, California, and New Jersey in the United States and in Sweden, France, The Netherlands, Germany and Estonia.
